OXSONICS THERAPEUTICS
OxSonics® Therapeutics’ proprietary platform technology, SonoTran®, is being developed to provide a step-change in the therapeutic index of anti-cancer agents without the development costs or delays associated with drug reformulation. SonoTran is designed to increase the dose and distribution of anti-cancer agents within solid tumours, thereby increasing the efficacy and/or reducing the toxicity of these agents across the majority of the most challenging solid tumour cancers. The approach ha... s been specifically designed to fit seamlessly into existing oncology clinical workflows, and has the major advantage of enabling healthcare professionals to see-as-they-treat by providing visualisation on-screen and in real time. The SonoTran drug delivery platform is based on ground-breaking technological advances, originally invented at the University of Oxford’s Institute of Biomedical Engineering. OxSonics is based in Oxford in the UK. For more information please visit: www.oxsonics.com.
OXSONICS THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Device
Founded:
2013-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.oxsonics.com
Total Employee:
11+
Status:
Active
Contact:
+4401865784777
Total Funding:
24.7 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag
Similar Organizations
Airify
Micro wearable and IoT air quality sensing devices for multi-context usage; up to 10 sensors; open platform; crowd-sourcing.
Bicycle Therapeutics
Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Chronolife
Chronolife builds predictive medical solutions to aid in diagnosis through a wireless, wearable technology.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Instylla
Instylla’s focus is to leverage hydrogel technology .
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Investors List
Oxford Technology Management
Oxford Technology Management investment in Series B - OxSonics Therapeutics
Perivoli Innovations
Perivoli Innovations investment in Series B - OxSonics Therapeutics
Winton Ventures
Winton Ventures investment in Series B - OxSonics Therapeutics
ForumOxford (at the University of Oxford)
ForumOxford (at the University of Oxford) investment in Series B - OxSonics Therapeutics
Longwall Venture Partners
Longwall Venture Partners investment in Series B - OxSonics Therapeutics
Innovate UK
Innovate UK investment in Grant - OxSonics Therapeutics
Official Site Inspections
http://www.oxsonics.com
- Host name: 5.207.195.35.bc.googleusercontent.com
- IP address: 35.195.207.5
- Location:
- Latitude: 47
- Longitude: 8
- Timezone: Europe/Vaduz
